By API User
Key Facts: Breast Cancer Network Australia (BCNA) is available to speak with media about it’s role in the Advanced Breast Cancer (ABC) Global Decade Report 2015–2025 launched today in Lisbon, Portugal. * A decade of significant progress in metastatic (treatable but incurable) breast cancer care. * Highlights critical gaps and inequalities in care around the … Continued
By API User
The Australian Indigenous Doctors’ Association (AIDA), the Australasian College for Emergency Medicine (ACEM) and the Royal Australasian College of Physicians (RACP) have united to make a stand for equity in healthcare. We support St Vincent’s Hospital Melbourne Chief Executive Nicole Tweddle’s statement reaffirming the hospital’s commitment to prioritising triage for all First Nations patients presenting to the Emergency Department (ED). St Vincent’s Hospital’s … Continued
By API User
A preventative health program designed to reach some of the most remote homes in the Northern Territory has received national recognition after claiming a top health award. The Outback Active team was awarded the Rural/Remote Health Innovator of the Year prize at the National Rural and Remote Health Awards at a ceremony in Canberra on … Continued
By API User
Nexsen Limited (ASX: NXN) (, a nano-biotechnology company developing an innovative point-of-care diagnostic platform, is pleased to announce the acceleration of its US market entry for its GBS Rapid Sensor and Kidney Function Diagnostics, with the appointment of an expert consultant advising the Company on its US FDA regulatory pathway. Appointment of MCRA Nexsen has … Continued
By API User
Highlights Updated U.S. insurance data identifies over ~2 million women per year1 could benefit from CLEO’s Pre-Surgical Ovarian Cancer Test Findings reinforce the unmet need and significant commercial potential for CLEO’s patented technology Data will inform a broader health economic study to support CLEO’s market entry, reimbursement and early revenue generation. ________________ MELBOURNE, AUSTRALIA, 6th November … Continued
By API User
Perth, Australia – 6 November 2025: NeuroScientific Biopharmaceuticals Limited (ASX: NSB), an innovative Australian biotechnology company developing novel technologies targeted at immune-mediated inflammatory diseases, is pleased to announce the appointment of its Clinical & Scientific Advisory Board with immediate effect. The Advisory Board will provide strategic guidance across scientific innovation, product development, clinical indications, and … Continued
By API User
Sunnyvale, California; 6 November 2025: EBR Systems, Inc. (ASX: “EBR”, “EBR Systems”, or the “Company”), developer of the world’s only wireless cardiac pacing device for heart failure, today announced that management will be participating at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 20, 2025 at The Westin Grand … Continued
By API User
Almost 50 per cent of women in midlife surveyed in a Monash University-led study had poor sexual wellbeing, including a doubling of the likelihood of desire and arousal dysfunction in early perimenopausal women from premenopause. Published in The Lancet Obstetrics, Gynaecology, & Women’s Health, the study, believed to be the largest of its kind, … Continued
By API User
Key points Viruses have the ability to ‘do so much with so little’ when they infect and ‘take over’ our cells Understanding how small viruses can do so much has been a major challenge Researchers have found an answer, which could change how we view viral biology New antivirals and vaccines could follow the … Continued
By API User
A new clinical trial will investigate an accelerated, less burdensome treatment to improve quality of life for people with brain cancer, supported with $1.49 million in funding from the Medical Research Future Fund. A WEHI-led team of clinicians and researchers will collaborate on the trial, focused on glioblastoma – a highly aggressive and lethal … Continued
